The French pharma company continues to pare down its central nervous system business by divesting 11 brands to U.K.-based Pharmanovia, which is expanding its neurology portfolio.
https://www.pharmalive.com/wp-content/uploads/2020/06/Sanofi-Streamlines-Pipeline-Focus-While-Looking-Ahead-to-a-Post-COVID-19-World-BioSapce-6-26-20.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2023-09-19 08:52:142023-09-19 08:52:14Sanofi sells 11 CNS assets to Pharmanovia including Frisium and Gardenal
